Aspira Pathlab & Diagnostics informs about disclosure

19 Mar 2024 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Shraddha Bhanushali, Directors Immediate Relative of the Company for the acquisition of Equity Shares from the market as on March 18, 2024.

The above information is a part of company’s filings submitted to BSE. 

Aspira Pathlab&Diagn Share Price

31.00 -0.73 (-2.30%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 362.80
Apollo Hospital Ent. 5850.75
Max Healthcare Inst 752.20
Narayana Hrudayalay 1190.00
Global Health 1192.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.